Detection of O-acetylated Vi polysaccharide of Salmonella enterica subspecies typhi by Enzyme Immunoassay

Biologicals

Volumn 32, Issue 1, 2004, Pages 11-16

  Rijpkema, Sjoerd ^a   Durrani, Zarmina ^a   Lemercinier, Xavier ^a   Jones, Christopher ^a  

^a NATIONAL INSTITUTE FOR BIOLOGICAL STANDARDS AND CONTROL   (United Kingdom)

Author keywords

Antiserum; EIA; O acetylation; Typhoid; Vi polysaccharide

Indexed keywords

ANTISERUM; BACTERIUM LIPOPOLYSACCHARIDE; TYPHOID VACCINE;

ACETYLATION; ARTICLE; CONTROLLED STUDY; GRAM NEGATIVE BACTERIUM; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; SALMONELLA ENTERICA; SALMONELLA TYPHI;

ACETYLATION; EPITOPES; ESCHERICHIA COLI; IMMUNOENZYME TECHNIQUES; LIPOPOLYSACCHARIDES; MAGNETIC RESONANCE SPECTROSCOPY; POLYSACCHARIDES, BACTERIAL; SALMONELLA TYPHI; SODIUM; SODIUM HYDROXIDE; TYPHOID FEVER; TYPHOID-PARATYPHOID VACCINES;

NEGIBACTERIA; SALMONELLA; SALMONELLA ENTERICA; SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHI; SALMONELLA TYPHI;

EID: 1542722945     PISSN: 10451056     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biologicals.2003.09.002     Document Type: Article

References (21)

1. Ivanoff B., Levine M.M. Typhoid fever: continuing challenges from a resilient bacterial foe. Bull Inst Pasteur. 95:1997;129-142.
2. Acharya I.L., Lowe C.U., Thapa R.T., et al. Prevention of typhoid fever in Nepal with the Vi capsular polysaccharide of Salmonella typhi. N Engl J Med. 317:1987;1101-1104.
3. Parry C., Wain J., Chinh N.T., Vinh H., Farrar J.J. Quinolone-resistant Salmonella typhi in Vietnam. Lancet. 351:1998;1289.
4. Stephens I., Levine M.M. Management of typhoid fever in children. Pediatr Infect Dis J. 21:2002;157-158.
5. Levine M.M., Ferreccio C., Abrego P., Martin O.S., Ortiz E., Cryz S. Duration of efficacy of Ty21a, attenuated Salmonella typhi live oral vaccine. Vaccine. 17:(Suppl 2):1999;S22-S27.
6. Klugman K.P., Gilbertson I.T., Koornhof H.J., et al. Protective activity of Vi capsular polysaccharide vaccine against typhoid fever. Lancet. 8569:1987;1165-1169.
7. Murphy J.R., Grez L., Schlesinger L., et al. Immunogenicity of Salmonella typhi Ty21a vaccine for young children. Infect Immun. 59:1991;4291-4293.
8. Szu S.C., Stone A.L., Robbins J.D., Schneerson R., Robbins J.B. Vi capsular polysaccharide-protein conjugates for prevention oftyphoid fever. Preparation, characterization, and immunogenicity in laboratory animals. J Exp Med. 166:1987;1510-1524.
9. Kossaczka Z., Lin F.Y., Ho V.A., et al. Safety and immunogenicity of Vi conjugate vaccines for typhoid fever in adults, teenagers, and 2- to 4-year-old children in Vietnam. Infect Immun. 67:1999;5806-5810.
10. Lin F.Y., Ho V.A., Khiem H.B., et al. The efficacy of a Salmonella typhi Vi conjugate vaccine in two to five year old children. N Engl J Med. 344:2001;1263-1269.
11. Felix A., Pitt R.M. A new antigen of B. typhosus. Its relation to virulence and to active and passive immunisation. Lancet. 227:1934;186-191.
12. Felix A. The titration of therapeutic anti-typhoid serum. J Hyg (Lond). 38:1938;750-771.
13. Robbins J.D., Robbins J.B. Reexamination of the protective role of the capsular polysaccharide (Vi antigen) of Salmonella typhi. J Infect Dis. 150:1984;436-449.
14. Martin D.G., Jarvis F.G., Milner K.C. Physicochemical and biological properties of sonically treated Vi antigen. J Bacteriol. 94:1967;1411-1416.
15. Szu S.C., Li X.R., Stone A.L., Robbins J.B. Relation between structure and immunologic properties of the Vi capsular polysaccharide. Infect Immun. 59:1991;4555-4561.
16. WHO Technical Report Series. Requirements for Vi polysaccharide typhoid vaccine, 1994;840:14-29.
17. European Pharmacopeia, edition 4.2. Typhoid polysaccharide vaccine, 2003, p. 2842-3.
18. Lemercinier X., Martinez C.I., Jones C. Use and validation of an NMR test for the identity and O-acetyl content of the Salmonella typhi Vi capsular polysaccharide vaccine. Biologicals. 28:2000;17-24.
19. Schneerson R., Barrera O., Sutton A., Robbins J.B. Preparation, characterization, and immunogenicity of Haemophilus influenzae type b polysaccharide-protein conjugates. J Exp Med. 152:1980;361-376.
20. Felix A., Pitt R.M. Virulence and immunogenic activities of B. typhosus in relation to its antigenic constituents. J Hyg (Lond). 35:1935;428-436.
21. Jones G.W., Abrams G.D., Freter R. Adhesive properties of Vibrio cholerae: adhesion to isolated rabbit brush border membranes and hemagglutinating activity. Infect Immun. 14:1976;232-239.